Carbaglu blev undersøgt hos 20 patienter, hvoraf 12 havde NAGS- mangel og var blevet behandlet gennemsnitligt ca. tre år.
Carbaglu has been studied in 20 patients, 12 of whom had NAGS deficiency and were treated for an average of about three years.